Abstract

BackgroundSmall supernumerary marker chromosomes (sSMCs) are rare structural abnormalities in the population; however, they are frequently found in children or fetuses with hypoevolutism and infertile adults. sSMCs are usually observed first by karyotyping, and further analysis of their molecular origin is important in clinical practice. Next-generation sequencing (NGS) combined with Sanger sequencing helps to identify the chromosomal origins of sSMCs and correlate certain sSMCs with a specific clinical picture.ResultsKaryotyping identified 75 sSMCs in 74,266 samples (0.1% incidence). The chromosomal origins of 27 of these sSMCs were detected by sequencing-related techniques (NGS, MLPA and STR). Eight of these sSMCs are being reported for the first time. sSMCs mainly derived from chromosomal X, Y, 15, and 18, and some sSMC chromosomal origins could be correlated with clinical phenotypes. However, the chromosomal origins of the remaining 48 sSMC cases are unknown. Thus, we will develop a set of economical and efficient methods for clinical sSMC diagnosis.ConclusionsThis study details the comprehensive characterization of 27 sSMCs. Eight of these sSMCs are being reported here for the first time, providing additional information to sSMC research. Identifying sSMCs may reveal genotype-phenotype correlations and integrate genomic data into clinical care.

Highlights

  • Small supernumerary marker chromosomes are rare structural abnormalities in the population; they are frequently found in children or fetuses with hypoevolutism and infertile adults. sSMCs are usually observed first by karyotyping, and further analysis of their molecular origin is important in clinical practice

  • It is known that 70% of sSMCs are de novo, 20% are inherited from the mother, and 10% come from the father [1]. sSMCs are often derived from maternal meiosis I/II errors, trisomic/monosomic rescue, or fertilization errors [2

  • We identified 75 sSMC cases in 74,266 patients seen in our department from 2015 to 2018 by karyotyping

Read more

Summary

Introduction

Small supernumerary marker chromosomes (sSMCs) are rare structural abnormalities in the population; they are frequently found in children or fetuses with hypoevolutism and infertile adults. sSMCs are usually observed first by karyotyping, and further analysis of their molecular origin is important in clinical practice. Small supernumerary marker chromosomes (sSMCs) are rare structural abnormalities in the population; they are frequently found in children or fetuses with hypoevolutism and infertile adults. SSMCs are usually observed first by karyotyping, and further analysis of their molecular origin is important in clinical practice. Small supernumerary marker chromosomes (sSMCs) are structural abnormalities whose origins cannot be characterized by conventional cytogenetics alone but require molecular approaches. 70% of sSMC carriers are clinically normal; 30% are abnormal. Patients carrying sSMCs have developmental delays, intellectual disabilities, mixed gonadal dysgenesis (MGS), or infertility, depending on the origin of the sSMC. The treatment of these patients was based on different symptoms until the molecular characterization of sSMCs was developed

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.